Arshad Jamil, General Manager, IPR, Biocon talks about Biocon’s IP strategy that is creating value by leveraging the potential of our innovative products & processes.
Kiran Mazumdar Shaw, CMD, Biocon shares her views on #Budget2017
Amitava Saha, Sr. VP & Head HR, Biocon shares his views on the role of Strategic HR in ensuring the success of today’s biotech M&As.
Wishing everyone a very Happy and Hopeful New Year 2017! 🙂
Diabetes & Diet FAQs: Geetha G H, dietitian, certified diabetes educator and sports nutritionist, answers your queries on how to fight diabetes with a balanced diet.
What kind of food can a person with diabetes eat and what kind of food should be avoided? How important is diet management in diabetes management? Find your answers here..
Biocon in its endeavour to fight diabetes is organising a webinar to create greater diabetes awareness and sensitize people with diabetes on life style modifications that could help them lead healthier and happier lives. Join us in 2 interactive webinars on November 23rd & November 28th, 2016 and help #BeatDiabetes! Eat Healthy! Live Healthy!!
Breast cancer is the second most common cancer in the world and, by far, the most frequent cancer among women. Every 19 seconds someone is diagnosed with breast cancer and every 74 seconds someone dies from it!
Biocon reported strong Q2FY17 results. Small Molecules, Biologics and Research Services businesses showed strong growth while it was a stand-out quarter for the Biologics business.
Part 2 – The potential financial benefits and better health outcomes from biosimilars use could spur their uptake in health systems globally.
Antimicrobial resistance (AMR) represents a global catastrophe that threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi.
By Sreesha Srinivasa, PhD
Associate Vice President, Research and Development, Biocon Research Limited.